- Home
- OPTN vs RVSB Comparison
OPTN vs RVSB Comparison
Compare OPTN & RVSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTN
- RVSB
- Stock Information
- Founded
- OPTN 2010
- RVSB 1923
- Country
- OPTN United States
- RVSB United States
- Employees
- OPTN N/A
- RVSB N/A
- Industry
- OPTN Biotechnology: Pharmaceutical Preparations
- RVSB Savings Institutions
- Sector
- OPTN Health Care
- RVSB Finance
- Exchange
- OPTN Nasdaq
- RVSB Nasdaq
- Market Cap
- OPTN 117.6M
- RVSB 99.6M
- IPO Year
- OPTN 2017
- RVSB 1993
- Fundamental
- Price
- OPTN $0.71
- RVSB $4.68
- Analyst Decision
- OPTN Strong Buy
- RVSB
- Analyst Count
- OPTN 2
- RVSB 0
- Target Price
- OPTN $4.00
- RVSB N/A
- AVG Volume (30 Days)
- OPTN 516.5K
- RVSB 25.0K
- Earning Date
- OPTN 11-07-2024
- RVSB 10-24-2024
- Dividend Yield
- OPTN N/A
- RVSB 1.71%
- EPS Growth
- OPTN N/A
- RVSB N/A
- EPS
- OPTN N/A
- RVSB 0.09
- Revenue
- OPTN $75,058,000.00
- RVSB $46,872,000.00
- Revenue This Year
- OPTN $24.44
- RVSB N/A
- Revenue Next Year
- OPTN $49.00
- RVSB $12.93
- P/E Ratio
- OPTN N/A
- RVSB $51.13
- Revenue Growth
- OPTN 3.91
- RVSB N/A
- 52 Week Low
- OPTN $0.65
- RVSB $3.30
- 52 Week High
- OPTN $2.10
- RVSB $6.57
- Technical
- Relative Strength Index (RSI)
- OPTN 33.40
- RVSB 57.21
- Support Level
- OPTN $0.65
- RVSB $4.62
- Resistance Level
- OPTN $0.70
- RVSB $4.74
- Average True Range (ATR)
- OPTN 0.05
- RVSB 0.09
- MACD
- OPTN -0.00
- RVSB -0.00
- Stochastic Oscillator
- OPTN 24.67
- RVSB 22.22
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. Its product includes XHANCE (fluticasone propionate) nasal spray, 93 micrograms, a therapeutic utilizing its proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids.
About RVSB Riverview Bancorp Inc
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.